The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ASTERIAS BIOTHERAPEUTICS INC COM SER A 04624N107 11,907 5,292,156 SH   DFND 1 5,292,156 0 0
AXON ENTERPRISE INC COM 05464C101 10,364 391,092 SH   DFND 1 391,092 0 0
BIOTIME INC COM 09066L105 64,439 29,971,561 SH   DFND 1 29,971,561 0 0
BOEING CO COM 097023105 32,440 110,000 SH Put DFND 1 110,000 0 0
DELTA AIR LINES INC DEL COM NEW 247361702 14,000 250,000 SH Put DFND 1 250,000 0 0
ISHARES TR RUSSELL 2000 ETF 464287655 64,033 420,000 SH   DFND 1 420,000 0 0
ONCOCYTE CORPORATION COM 68235C107 16,725 3,596,680 SH   DFND 1 3,596,680 0 0
MONSTER BEVERAGE CORP NEW COM 61174X109 303,628 4,797,408 SH   DFND 1 4,797,408 0 0
MONSTER BEVERAGE CORP NEW COM 61174X109 31,645 500,000 SH Put DFND 1 500,000 0 0
STAAR SURGICAL CO COM PAR $0.01 852312305 168,255 10,855,179 SH   DFND 1 10,855,179 0 0